Cargando…

Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions

Detalles Bibliográficos
Autores principales:	Wiendl, Heinz, Gold, Ralf, Zipp, Frauke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344158/ https://www.ncbi.nlm.nih.gov/pubmed/34362473 http://dx.doi.org/10.1186/s42466-021-00140-1

Ejemplares similares

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
por: Wiendl, Heinz, et al.
Publicado: (2021)

Kommentar der Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) zur S2k-Leitlinie Multiple Sklerose
por: Wiendl, Heinz, et al.
Publicado: (2021)

Questions & Answers discussion
por: Henriques, Andre
Publicado: (2023)

Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis
por: Trinschek, Bettina, et al.
Publicado: (2013)

NUFACT11 round table discussion: questions and answers
por: Blondel, A, et al.
Publicado: (2013)

Correction: Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis
por: Trinschek, Bettina, et al.
Publicado: (2013)

Automatic question answering for multiple stakeholders, the epidemic question answering dataset
por: Goodwin, Travis R., et al.
Publicado: (2022)

NCI's provocative questions on cancer: some answers to ignite discussion
por: Blagosklonny, Mikhail V.
Publicado: (2011)

Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis
por: Deppe, Michael, et al.
Publicado: (2014)

What Have Failed, Interrupted, and Withdrawn Antibody Therapies in Multiple Sclerosis Taught Us?
por: Krämer, Julia, et al.
Publicado: (2022)

Role of RGC-32 in multiple sclerosis and neuroinflammation – few answers and many questions
por: Tatomir, Alexandru, et al.
Publicado: (2022)

MULTIPLE CHOICE QUESTIONS IN HUMAN PHYSIOLOGY: with Answers and Comments
Publicado: (1971)

AIDS: questions and answers
Publicado: (1987)

QUESTIONS AND ANSWERS FOR THE DRCOG
por: Costa, Janitha
Publicado: (2011)

Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders
por: Brummer, Tobias, et al.
Publicado: (2021)

Morbid curiosity? Discussion of the disposal of amputated limbs on online question and answer sites
por: Hanna, Esmée
Publicado: (2019)

Sanitary Law—In Question and Answer
Publicado: (1932)

Preventing disease progression in multiple sclerosis—insights from large real-world cohorts
por: Engel, Sinah, et al.
Publicado: (2022)

Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
por: Centonze, Diego, et al.
Publicado: (2021)

Questions & Answers
por: CERN. Geneva
Publicado: (2019)

Questions and answers
por: Jones, Rhodri, et al.
Publicado: (2023)

Questions and answers
por: Jones, Rhodri, et al.
Publicado: (2022)

Questions and Answers
Publicado: (1887)

The Question Answered
por: Smith, C. Carleton
Publicado: (1881)

Questions and Answers
Publicado: (1895)

Neurosurgery Rounds: Questions and Answers
por: Buchanan, Colin C.
Publicado: (2011)

Questions and Answers on the Essentials of Physiology
Publicado: (1888)

Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy
por: Heming, Michael, et al.
Publicado: (2023)

Association of obesity with disease outcome in multiple sclerosis
por: Lutfullin, Isabel, et al.
Publicado: (2023)

Public Health Law in Question and Answer
Publicado: (1953)

Examination Questions in Practice of Medicine, with Answers
Publicado: (1894)

Examination Questions in Practice of Medicine, with Answers
Publicado: (1892)

Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
por: Ruck, Tobias, et al.
Publicado: (2015)

Unmet needs in clinical trials in CKD: questions we have not answered and answers we have not questioned
por: Levin, Adeera, et al.
Publicado: (2022)

Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets
por: Gold, Ralf, et al.
Publicado: (2021)

The potential of serum neurofilament as biomarker for multiple sclerosis
por: Bittner, Stefan, et al.
Publicado: (2021)

Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
por: Bock, Markus, et al.
Publicado: (2021)

Very short answer questions: a viable alternative to multiple choice questions
por: Puthiaparampil, Thomas, et al.
Publicado: (2020)

MRD in multiple myeloma: more questions than answers?
por: Moreau, Philippe, et al.
Publicado: (2017)

Questions and Answers to panellists
por: Wijnands, Thijs
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2b6g4n5hehogtrhqlm25ulvdb4